Replies

A commenter at ZeroHedge wrote:

One avenue that hasn’t gotten much mainstream attention yet that I believe merits looking into is the route of Antibody dependent enhancement (ADE). S. Zhengli, one of the scientists mentioned in this article, published a paper on how Coronavirus can utilize ADE... https://www.ncbi.nlm.nih.gov/pubmed/31826992

So WTF is ADE? https://en.wikipedia.org/wiki/Antibody-dependent_enhancement

Read up on Dengue Hemorraghic Fever... the first infection isn’t so bad, it’s the 2nd one that kills due to the virus now gaining entry to immune cells, triggering hyperactive immune response, cytokine storm, etc.

Why is it that this virus starts out with mild symptoms, sniffles, cough, etc.? And serious symptoms take much longer for onset? The ADE theory makes sense to me. In a place like Wuhan, reinfection is practically guaranteed due to the constant population reservoir, while in countries where the virus is relatively contained, reinfection is much less likely. Which could explain why we haven’t really seen deaths yet in countries where the virus is just recently introduced.

What’s effin scary about this theory is that a vaccine won’t make any sense—the antibodies would merely set you up for the lethal pathway. Pray to God that this isn’t true. But seeing the chemical spraying of the streets and the propaganda machine in hyperdrive isn’t too comforting.

Expanding on this, I’d expect medical crews to be much more susceptible to reinfection. Dr. Li Wenliang dying recently stands out, only 34, started coughing on Jan 10th... 27 days to succumb to this.

Also, consider the case study of the first US patient in Washington State : https://www.nejm.org/doi/10.1056/NEJMoa2001191

If you add the days from when he was asymptomatic and began coughing prior to checking in to the hospital to the days of the case study, it’s roughly two weeks until he started to deteriorate... roughly the time for the body to begin antibody production. They did use Remdesivir, which was able to help him turn things around—it’s a protease inhibitor. Note that this man also was only 35 years old, you’d expect a healthy, strong immune response.

I think we should continue to watch areas with sustained local infection reservoirs and monitor the long-term status of the first infected, to see if they relapse. I just don’t trust what China’s putting out right now. Next likely candidates to monitor will be Japan, Hong Kong, and other neighboring but less oppressive Asia states to see how their nCoV infections progress.